Ferric derisomaltose versus usual care in patients with heart failure, reduced ejection fraction, and iron deficiency: a short-term UK cost-utility analysis based on the IRONMAN RCT

1 September 2024 (16:05 - 16:15)
Organised by: Logo
Congress Presentation Part of: Collateral damage in heart failure: comorbidities and their treatment Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology